Jiwa Bio-Pharm Holdings Ltd operates in the Pharmaceutical preparations sector. Jiwa Bio-Pharm Holdings Limited is a Hong Kong-based investment holding company. The Company, through its subsidiaries, is engaged in the research, manufacturing and trading of pharmaceutical and healthcare products. The Company has manufacturing plants and sells mainly in the People's Republic of China. It operates in four segments: pharmaceutical products segment, which is engaged in manufacturing and sale of pharmaceutical products; trading pharmaceutical and health care products segment, which is engaged in trading of pharmaceutical and health care products; Distributions segment, which is engaged in distribution of pharmaceutical products, and pharmaceutical bulk materials segment, which is engaged in manufacturing and sale of pharmaceutical bulk materials. Its products include reduced glutathione for injection (Gluthion Song Taisi), triamcinolone acetonide injection (Transton) and tamsulosin hydrochloride (Jida Bente). In
our complete report available for purchase the company is compared to: United Gene High-Tech Group Limited, Hua Han Bio-Pharmaceutical Holdings Ltd and Anxin-China Holdings Limited.